Charles River Laboratories | CRL - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Agilent USD 6.91B 167M 2025-12
Align Technology USD 4.15B 100.27M 2026-03
Bio-Rad Laboratories USD 6.85B 602.3M 2026-03
Bruker USD 2.46B 35.9M 2025-12
Cardinal Health USD -2.83B 52M 2026-03
Charles River Laboratories USD 2.9B 265.94M 2026-03
Cigna USD 42.21B 497M 2026-03
Concord Medical Services Hldg CNY -2.24B 362.55M 2025-06
CVS Health USD 77.46B 2.24B 2026-03
Danaher USD 52.95B 415M 2026-03
Dentsply International USD 1.32B 21M 2026-03
Elevance Health USD 43.9B 124M 2026-03
Humana USD 18.58B 923M 2026-03
Illumina USD 2.68B 47M 2026-03
Incyte USD 5.62B 455.37M 2026-03
Intrexon USD 43.17M 75.33M 2024-06
IQVIA Holdings USD 6.22B 282M 2026-03
Laboratory Of America USD 8.73B 108.8M 2026-03
Lakefront Biotherapeutics EUR 3.25B 17.5M 2026-03
Lonza CHF 9.13B 513M 2025-12
McKesson USD -2.17B 874M 2026-03
Merck EUR 29.74B 1.15B 2026-03
Mettler Toledo International USD -41.88M 18.25M 2026-03
Novartis USD 38.93B 7.2B 2026-03
Pfizer USD 90.1B 3.63B 2026-03
Quest Diagnostics USD 7.37B 196M 2026-03
Revvity USD 7.25B 125.54M 2025-12
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
United Therapeutics USD 5.9B 1.2B 2026-03
UnitedHealth USD 101.7B 4.12B 2025-12
Veradigm USD 1.02B 159.52M 2022-12
Waters USD 2.56B 230.55M 2025-12
West Pharmaceutical Services USD 2.99B 185.6M 2026-03